stella
beta
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea — Stella
Recruiting
Back to Moderate-to-severe Plaque Psoriasis trials
Trial locations
(2 sites)
South Korea
Local Institution - 0001, Seoul
Novotech Laboratory Korea Co., Ltd., Seoul
View full record on ClinicalTrials.gov